Advertisement
ATRC vs PEN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Buy and PEN is a Hold.
ATRC's Stochastic Oscillator is sitting in oversold zone for 1 day
Be on the lookout for a price bounce soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +9.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRC advanced for three days, in 212 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 182 of 244 cases where ATRC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
Bearish Trend Analysis
The 10-day RSI Indicator for ATRC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 23 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.
The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ATRC as a result. In 70 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for ATRC turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 35 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
ATRC moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
ATRC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. ATRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.766) is normal, around the industry mean (4.964). ATRC's P/E Ratio (266.091) is considerably higher than the industry average of (40.591). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (4.869) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
PEN sees MACD Histogram crosses below signal line
PEN saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 30, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In 31 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 70%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for PEN moved out of overbought territory on October 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 27 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 55 cases where PEN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 64%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PEN as a result. In 46 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
PEN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
PEN moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PEN crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +1.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where PEN advanced for three days, in 197 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 152 of 240 cases where PEN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. PEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.214) is normal, around the industry mean (4.142). P/E Ratio (77.856) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (3.597) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (8.354) is also within normal values, averaging (40.124).
ATRC | PEN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 81 | 86 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 93 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 76 | |
SMR RATING 1..100 | 88 | 66 | |
PRICE GROWTH RATING 1..100 | 35 | 50 | |
P/E GROWTH RATING 1..100 | 7 | 21 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ATRC's Valuation (92) in the Medical Specialties industry is in the same range as PEN (93). This means that ATRC’s stock grew similarly to PEN’s over the last 12 months.
PEN's Profit vs Risk Rating (76) in the Medical Specialties industry is in the same range as ATRC (100). This means that PEN’s stock grew similarly to ATRC’s over the last 12 months.
PEN's SMR Rating (66) in the Medical Specialties industry is in the same range as ATRC (88). This means that PEN’s stock grew similarly to ATRC’s over the last 12 months.
ATRC's Price Growth Rating (35) in the Medical Specialties industry is in the same range as PEN (50). This means that ATRC’s stock grew similarly to PEN’s over the last 12 months.
ATRC's P/E Growth Rating (7) in the Medical Specialties industry is in the same range as PEN (21). This means that ATRC’s stock grew similarly to PEN’s over the last 12 months.
| ATRC | PEN | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 77% | 2 days ago 69% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 64% |
| Momentum ODDS (%) | 2 days ago 88% | 2 days ago 53% |
| MACD ODDS (%) | 2 days ago 74% | 2 days ago 70% |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 71% |
| Advances ODDS (%) | 8 days ago 70% | 23 days ago 65% |
| Declines ODDS (%) | 2 days ago 82% | 6 days ago 62% |
| BollingerBands ODDS (%) | 2 days ago 66% | 2 days ago 58% |
| Aroon ODDS (%) | 2 days ago 75% | 2 days ago 63% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ATRC’s FA Score shows that 1 FA rating(s) are green while PEN’s FA Score has 1 green FA rating(s).
- ATRC’s FA Score: 1 green, 4 red.
- PEN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ATRC’s TA Score shows that 3 TA indicator(s) are bullish while PEN’s TA Score has 4 bullish TA indicator(s).
- ATRC’s TA Score: 3 bullish, 6 bearish.
- PEN’s TA Score: 4 bullish, 6 bearish.
Price Growth
ATRC (@Pharmaceuticals: Other) experienced а -6.87% price change this week, while PEN (@Medical/Nursing Services) price change was +0.45% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
Reported Earning Dates
ATRC is expected to report earnings on Feb 23, 2027.
PEN is expected to report earnings on Feb 23, 2027.
Industries' Descriptions
@Pharmaceuticals: Other (+1.96% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
ATRC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then CERS could also see price increases.
| Ticker / NAME | Correlation To ATRC | 1D Price Change % | ||
|---|---|---|---|---|
| ATRC | 100% | -2.63% | ||
| CERS - ATRC | 42% Loosely correlated | -5.80% | ||
| SIBN - ATRC | 41% Loosely correlated | -1.95% | ||
| IRMD - ATRC | 38% Loosely correlated | -0.25% | ||
| ICUI - ATRC | 38% Loosely correlated | +1.82% | ||
| TMCI - ATRC | 37% Loosely correlated | +2.09% | ||
More | ||||
PEN and
Correlation & Price change
A.I.dvisor indicates that over the last year, PEN has been loosely correlated with ISRG. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To PEN | 1D Price Change % | ||
|---|---|---|---|---|
| PEN | 100% | -0.12% | ||
| ISRG - PEN | 42% Loosely correlated | -2.28% | ||
| HAE - PEN | 42% Loosely correlated | +3.51% | ||
| MMSI - PEN | 35% Loosely correlated | -0.69% | ||
| SMTI - PEN | 34% Loosely correlated | -1.37% | ||
| ATRC - PEN | 33% Loosely correlated | -2.63% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FCFY | 31.27 | N/A | N/A |
| First Trust S&P 500 Diversified Free Cash Flow ETF (FCFY) | |||
| CBIL | 24.85 | N/A | N/A |
| Corgi 3-12 Month T-Bill ETF (CBIL) | |||
| ISVL | 52.28 | -0.05 | -0.10% |
| iShares International Developed Small Cap Value Factor ETF (ISVL) | |||
| BCAT | 13.49 | -0.22 | -1.60% |
| BlackRock Capital Allocation Term Trust | |||
| SOLZ | 8.21 | -0.32 | -3.79% |
| Solana ETF (SOLZ) | |||